Takeda’s plasma-derived therapies (PDT) business tackles supply-chain challenges to expand access to life-saving treatments, ...

Guillain-Barré Syndrome occurs when the body’s immune system mistakenly attacks nerve cells, disrupting communication between ...

Guillain-Barré Syndrome (GBS) is a rare but potentially life-threatening neurological condition that can cause rapid muscle ...

The Aurora Xi Plasmapheresis System now benefits from enhanced capabilities that allow plasma centers to improve collection efficiency and support a greater supply of plasma-derived therapies.

The first death due to Guillain Barre Syndrome (GBS) has been reported at Govt General Hospital (GGH) in Guntur. Kamalamma, a ...

Earlier, a 53-year-old man had also died due to GBS at a hospital in Maharashtra’s Mumbai, the first fatality in the city due ...

--(BUSINESS WIRE)--#FreseniusKabi--Fresenius Kabi, an operating company of Fresenius, specializing in lifesaving medicines and technologies, announced today that the U.S. Food and Drug Administration ...

In mid-2024, the patient underwent a kidney transplant. Though he was relatively young for a transplant, that’s not where he ...

GBS outbreak: As Maharashtra continues to grapple with Guillain – Barre Syndrome (GBS), Andhra Pradesh has reported two ...

GBS is a rare condition in which a person's immune system attacks the peripheral nerves, resulting in muscle weakness, loss ...